Skelbimas
The Science Behind Etomidate: Uses, Benefits, and Risks
Kategorija:
Kosmetika
Kaina: 1900.00 €
Aprašymas:
The Science Behind Etomidate: Uses, Benefits, and Risks
Etomidate is a specialized pharmaceutical compound widely valued in research and laboratory settings for its predictable clinical effects and high purity. Researchers, scientific institutions, and qualified professionals select etomidate due to its rapid onset, stable hemodynamic profile, and rigorously controlled purity verified by advanced laboratory methods.
Pharmaceutical-grade etomidate is available as a crystalline powder and in precision-designed pod systems that meet the requirements of modern laboratory protocols. These products - such as the Crown King K-pod, Ferrari Etomidate Podk, and Martel Vsop Etomidate kpod - are engineered with strict quality control, including HPLC purity analysis guaranteeing a minimum of 99.9% verified content. Every batch receives a certificate of analysis, supporting transparent documentation and compliance.
All etomidate products are distributed with same-day dispatch, Stealth and Decoy packaging for absolute discretion, and privacy-focused worldwide shipping. Orders are covered by a comprehensive delivery guarantee, including complimentary reshipment for customs or courier-related losses. To maintain privacy and security for the global research community, transactions are processed exclusively through cryptocurrency payment methods (BTC, ETH, USDT).
Strict legal and compliance warnings apply: Etomidate and all etomidate-containing pod systems are strictly for controlled research, laboratory, or scientific study by adults aged 21 and older. Products are not for human consumption, medical therapy, or use by or sale to minors. Regulations regarding research chemical importation and handling differ by country; always review local laws and requirements. All information provided herein is intended for informational purposes only and should not be interpreted as clinical or medical advice.
What Etomidate Is
Etomidate is a synthetic imidazole derivative classified among short-acting general anesthetic agents. Its pharmacologic profile is carefully documented, making it essential for precise research protocols that demand rapid, controllable onset with minimal cardiovascular disturbance.
Definition and Drug Class of Etomidate
Etomidate is a non-barbiturate, non-benzodiazepine hypnotic agent used for induction of anesthesia in controlled settings.
The compound acts as a potent modulator of the GABA (gamma-aminobutyric acid) type A receptor, inducing hypnosis via central nervous system depression.
In research contexts, etomidate is prepared as a sterile powder or in pod systems designed to maintain absolute chemical integrity and dosing precision.
How Etomidate Works in the Body
Etomidate binds to and potentiates GABA-A receptors, enhancing chloride ion influx and neuronal inhibition.
The onset of action is typically seen within 30–60 seconds of intravenous administration.
The effect dissipates quickly (5–15 minutes) due to redistribution from the brain to peripheral tissues, not rapid hepatic clearance.
Etomidate causes little suppression of blood pressure or cardiac function, distinguishing it from several other induction agents and making it important for use in subjects with cardiovascular sensitivity.
Uses of Etomidate
Etomidate is used primarily in research and specialized medical environments focused on anesthesia, sedation, and related pharmacodynamic studies. Key uses include:
Induction of general anesthesia: As the initial hypnotic agent for procedures requiring rapid and controlled loss of consciousness.
Rapid sequence intubation (RSI): Deployed for intubation where preservation of blood pressure is critical, such as in hemodynamically unstable subjects.
Short procedural sedation: Utilized when a brief, reversible hypnotic effect is needed for minimally invasive laboratory or diagnostic processes.
Less common and off-label research uses: Includes comparative studies of anesthetic mechanisms, endocrine modulation, and detailed investigation of CNS depressant effects under strict laboratory protocols.
All such uses must comply with research governance, and access is restricted to adults aged 21 and older for legitimate scientific or laboratory application only.
Benefits of Etomidate
Etomidate offers distinct advantages for professional researchers and clinicians who require predictable hypnotic action with minimal risk of compromising hemodynamics.
Hemodynamic stability during administration: Etomidate is renowned for preserving blood pressure and cardiac output, which is crucial when studying or intervening in subjects with circulatory vulnerability.
Fast onset and short duration of effect: Rapid induction (within 30–60 seconds) and brief hypnosis (about 5–15 minutes) provide precise control of protocol windows and facilitate tight procedural scheduling.
Suitability for unstable or sensitive patients: When cardiovascular depression poses excessive risk, etomidate’s profile provides a safer research alternative.
Purity and analytic integrity are paramount. All etomidate products provided are HPLC-tested, with 99.9% minimum purity confirmed. For documentation and process transparency, see About Our Laboratory-Tested Etomidate Purity Standards.
Detailed listings and custom options for research powders and pod-based delivery can be found by visiting Browse Pharmaceutical-grade Etomidate Products.
Risks and Side Effects
Research use of etomidate requires full awareness of its risk spectrum and side effect profile. Proper monitoring and compliance with research protocols are essential.
Adrenal suppression risks and physiological impact: Etomidate inhibits adrenal 11β-hydroxylase, reducing cortisol synthesis even after a single dose. This can last from 6 to 24 hours and may impair the ability to handle physiological stress in susceptible models.
Incidence and nature of myoclonus: Transient skeletal muscle jerking (myoclonus) occurs frequently, potentially complicating study procedures or data collection. Pretreatment strategies using other agents are often investigated to minimize this effect.
Injection pain and venous irritation: Reports of local discomfort, burning, or even phlebitis at injection sites are common. Pod systems may alter the administration route but do not eliminate discomfort risks.
Nausea, vomiting, and recovery effects: Mild to moderate gastrointestinal symptoms can occur post-administration. Extended or severe reactions are rare but should be anticipated with protocols for management.
Repeated or prolonged exposure to etomidate increases the risk of cumulative adrenal suppression and is not supported outside closely regulated single-dose protocols. Devices such as the Lamborghini Etomidate Kpod or Lucifer Etomidate KPod are engineered to support strictly controlled, short-term research scenarios.
For further information on test standards and handling, refer to About Our Laboratory-Tested Etomidate Purity Standards.
Guidance on Usage and Caution
Cautious, ethical administration is central to etomidate research. Certain populations and conditions demand careful review or indicate avoidance altogether.
Considerations for sepsis and critically ill subjects:
Subjects experiencing sepsis or critical illness risk relative adrenal insufficiency with etomidate exposure. Studies in these models require thorough justification, alternate agent consideration, and robust safety protocols.
Adrenal insufficiency risks:
Any history or suspicion of baseline adrenal dysfunction should prompt exclusion due to heightened suppression risk.
Pregnancy and special population advisories:
Experimental use in pregnant or lactating subjects, minors, or individuals with unclear health status is prohibited by research ethics standards and local regulations. Defer to institutional and jurisdictional guidelines.
Researchers must align all acquisition and use of etomidate with ethical review standards, import/export constraints, and subject safety protocols. For information on logistics, privacy, and compliance with international regulations, reference Information on Discreet Worldwide Shipping.
Dosing and Administration Basics
All information here is strictly for qualified laboratory personnel operating in compliance with research governance. It is not a substitute for clinical protocol or patient care guidance.
Pharmaceutical-grade etomidate is distributed as highly pure powder or in advanced pod systems, each with calibrated dosing and preparation documentation. Rigorous protocols and monitoring are a prerequisite for use.
Standard intravenous dosing guidelines:
Most protocols specify 0.3 mg/kg administered intravenously in a single exposure to induce hypnosis.
Measured onset occurs within roughly 30–60 seconds; recovery follows in 5–15 minutes barring protocol-specific deviations.
Pod system dosing and administration must conform to device specifications and laboratory procedure manuals.
Pre-administration safety checklist:
Confirm adult status (21+), pregnancy exclusion, and no history of adrenal disorders.
Review and adhere to institutional approval processes.
Ensure fully functional monitoring for cardiovascular and airway status.
Prepare for emergency intervention in event of hypotension, adrenal crisis, or airway events.
Fully document and obtain consent for any at-risk models or protocols.
Monitoring recommendations during and after dosing:
Continuous cardiovascular and respiratory tracking throughout exposure and emergence.
Identify and document myoclonus, nausea, or unexpected delayed recovery promptly.
Monitor adrenal profiles in protocols that extend exposure or involve post-stress assessments.
Pharmaceutical-grade powders and pod-system options are available to support a wide range of research needs, from protocol-driven small studies to larger scale investigations. See Browse Pharmaceutical-grade Etomidate Products for up-to-date inventory, laboratory batch documentation, and device/system specifications matched to experimental needs, including Marbo Etomidate K-pod and Gucci Etomidate K-Pod configurations.
Best Practice Considerations in Research Use
Selecting etomidate as the hypnotic agent of choice in research studies involves balancing its unique benefits against the documented risks and considering logistics such as shipping, privacy, and local regulatory issues. Many laboratories prefer the privacy and reliability offered by cryptocurrency payments and Stealth packaging, minimizing risk of interference or exposure.
Research Scenario
Etomidate Advantages
Main Risks
Recommended Alternatives
Induction in unstable hemodynamics
Maintains blood pressure/cardiac output
Adrenal suppression
Agents with less impact on adrenal physiology
Rapid sequence intubation (RSI)
Rapid onset, preserves hemodynamics
Myoclonus, adrenal suppression
Consider alternative hypnotics if suitable
Short procedural sedation (labs)
Fast onset, brief effect Window
Injection pain, adrenal risk
Local anesthetics or benzodiazepines
Critically ill/septic subjects
Hemodynamic stability possible
High risk for adrenal crisis
Often best to avoid unless no alternatives
Repeated/prolonged dosing
N/A
Severe adrenal suppression
Not recommended; use alternatives
Best practice strategies:
Limit administration to single or minimal exposures.
Exclude vulnerable populations whenever possible.
Employ careful pre-administration screening and ongoing monitoring.
Mitigate myoclonus with pre-treatment or alternative protocol designs.
Request and retain comprehensive batch documentation to confirm laboratory analytic purity.
Logistics, privacy, and cross-border research requirements are addressed with secure packaging, tracked shipments, and delivery guarantees. To learn more, visit Information on Discreet Worldwide Shipping.
Frequently Asked Questions About Etomidate
What is etomidate used for?
Etomidate is utilized for the induction of general anesthesia and for short-term hypnosis in laboratory research, particularly when hemodynamic stability is required.
Why is etomidate preferred in some intubations?
It preserves blood pressure and heart rate during induction, which is critical where cardiovascular fluctuations would complicate research or patient safety.
Does etomidate lower blood pressure?
Etomidate generally maintains blood pressure at recommended doses, differing from many hypnotic or anesthetic competitors.
What is the main risk of etomidate?
The primary safety concern is transient suppression of adrenal steroid synthesis, which can be harmful in stress, infection, or prolonged protocols.
How long does adrenal suppression last?
Adrenal suppression from a typical dose may last six to twenty-four hours. The risk grows with repeated dosing or in vulnerable subjects.
Is etomidate safe in sepsis or shock?
Use in septic or shocked models is controversial, as adrenal crisis is possible. Expert consultation and alternative choices are advised.
What causes etomidate-induced myoclonus?
Transient disinhibition of central nervous system pathways leads to muscle jerking, which may require protocol modifications or additional agents to minimize.
Can etomidate be used for procedural sedation?
Etomidate can provide short procedural sedation under strict protocols, but is not appropriate for repeated or extended sedation due to cumulative endocrine effects.
What are common side effects after administration?
Myoclonus, pain or burning at the administration site, and transient nausea or vomiting are regularly observed, though typically mild.
How does etomidate differ from other induction agents?
Etomidate"s neutral effect on blood pressure and cardiac output distinguishes it from other anesthetics, but its potential for adrenal suppression requires more careful oversight.
To address additional queries or detail, see Frequently Asked Questions about Etomidate and Research Chemicals.
Compliance and Safety Notice:
All etomidate products - powder and pod-based - are intended strictly for research purposes in adult (21+) laboratories and qualified professional environments. Not for any form of human consumption, direct clinical treatment, or sale to minors. Researchers must review and comply with all institutional, legal, and regulatory requirements prior to purchase or handling. The information presented is informational and not clinical advice; no warranty of suitability for unauthorized uses is implied.
Discerning laboratories and scientific professionals can rely on our commitment to rigorous analytic standards, complete privacy, and global accessibility. Every order is handled with same-day dispatch, privacy-centric packaging, and delivery guarantees, supported by cryptocurrency payment processing for unmatched discretion.
For product information, specialized batch needs, or to discuss research logistics, Contact Us for Research-Grade Etomidate Inquiries.
https://etomidatekpods.com
https://etomidatekpods.com
https://etomidatekpods.com
The Science Behind Etomidate: Uses, Benefits, and Risks
Etomidate is a specialized pharmaceutical compound widely valued in research and laboratory settings for its predictable clinical effects and high purity. Researchers, scientific institutions, and qualified professionals select etomidate due to its rapid onset, stable hemodynamic profile, and rigorously controlled purity verified by advanced laboratory methods.
Pharmaceutical-grade etomidate is available as a crystalline powder and in precision-designed pod systems that meet the requirements of modern laboratory protocols. These products - such as the Crown King K-pod, Ferrari Etomidate Podk, and Martel Vsop Etomidate kpod - are engineered with strict quality control, including HPLC purity analysis guaranteeing a minimum of 99.9% verified content. Every batch receives a certificate of analysis, supporting transparent documentation and compliance.
All etomidate products are distributed with same-day dispatch, Stealth and Decoy packaging for absolute discretion, and privacy-focused worldwide shipping. Orders are covered by a comprehensive delivery guarantee, including complimentary reshipment for customs or courier-related losses. To maintain privacy and security for the global research community, transactions are processed exclusively through cryptocurrency payment methods (BTC, ETH, USDT).
Strict legal and compliance warnings apply: Etomidate and all etomidate-containing pod systems are strictly for controlled research, laboratory, or scientific study by adults aged 21 and older. Products are not for human consumption, medical therapy, or use by or sale to minors. Regulations regarding research chemical importation and handling differ by country; always review local laws and requirements. All information provided herein is intended for informational purposes only and should not be interpreted as clinical or medical advice.
What Etomidate Is
Etomidate is a synthetic imidazole derivative classified among short-acting general anesthetic agents. Its pharmacologic profile is carefully documented, making it essential for precise research protocols that demand rapid, controllable onset with minimal cardiovascular disturbance.
Definition and Drug Class of Etomidate
Etomidate is a non-barbiturate, non-benzodiazepine hypnotic agent used for induction of anesthesia in controlled settings.
The compound acts as a potent modulator of the GABA (gamma-aminobutyric acid) type A receptor, inducing hypnosis via central nervous system depression.
In research contexts, etomidate is prepared as a sterile powder or in pod systems designed to maintain absolute chemical integrity and dosing precision.
How Etomidate Works in the Body
Etomidate binds to and potentiates GABA-A receptors, enhancing chloride ion influx and neuronal inhibition.
The onset of action is typically seen within 30–60 seconds of intravenous administration.
The effect dissipates quickly (5–15 minutes) due to redistribution from the brain to peripheral tissues, not rapid hepatic clearance.
Etomidate causes little suppression of blood pressure or cardiac function, distinguishing it from several other induction agents and making it important for use in subjects with cardiovascular sensitivity.
Uses of Etomidate
Etomidate is used primarily in research and specialized medical environments focused on anesthesia, sedation, and related pharmacodynamic studies. Key uses include:
Induction of general anesthesia: As the initial hypnotic agent for procedures requiring rapid and controlled loss of consciousness.
Rapid sequence intubation (RSI): Deployed for intubation where preservation of blood pressure is critical, such as in hemodynamically unstable subjects.
Short procedural sedation: Utilized when a brief, reversible hypnotic effect is needed for minimally invasive laboratory or diagnostic processes.
Less common and off-label research uses: Includes comparative studies of anesthetic mechanisms, endocrine modulation, and detailed investigation of CNS depressant effects under strict laboratory protocols.
All such uses must comply with research governance, and access is restricted to adults aged 21 and older for legitimate scientific or laboratory application only.
Benefits of Etomidate
Etomidate offers distinct advantages for professional researchers and clinicians who require predictable hypnotic action with minimal risk of compromising hemodynamics.
Hemodynamic stability during administration: Etomidate is renowned for preserving blood pressure and cardiac output, which is crucial when studying or intervening in subjects with circulatory vulnerability.
Fast onset and short duration of effect: Rapid induction (within 30–60 seconds) and brief hypnosis (about 5–15 minutes) provide precise control of protocol windows and facilitate tight procedural scheduling.
Suitability for unstable or sensitive patients: When cardiovascular depression poses excessive risk, etomidate’s profile provides a safer research alternative.
Purity and analytic integrity are paramount. All etomidate products provided are HPLC-tested, with 99.9% minimum purity confirmed. For documentation and process transparency, see About Our Laboratory-Tested Etomidate Purity Standards.
Detailed listings and custom options for research powders and pod-based delivery can be found by visiting Browse Pharmaceutical-grade Etomidate Products.
Risks and Side Effects
Research use of etomidate requires full awareness of its risk spectrum and side effect profile. Proper monitoring and compliance with research protocols are essential.
Adrenal suppression risks and physiological impact: Etomidate inhibits adrenal 11β-hydroxylase, reducing cortisol synthesis even after a single dose. This can last from 6 to 24 hours and may impair the ability to handle physiological stress in susceptible models.
Incidence and nature of myoclonus: Transient skeletal muscle jerking (myoclonus) occurs frequently, potentially complicating study procedures or data collection. Pretreatment strategies using other agents are often investigated to minimize this effect.
Injection pain and venous irritation: Reports of local discomfort, burning, or even phlebitis at injection sites are common. Pod systems may alter the administration route but do not eliminate discomfort risks.
Nausea, vomiting, and recovery effects: Mild to moderate gastrointestinal symptoms can occur post-administration. Extended or severe reactions are rare but should be anticipated with protocols for management.
Repeated or prolonged exposure to etomidate increases the risk of cumulative adrenal suppression and is not supported outside closely regulated single-dose protocols. Devices such as the Lamborghini Etomidate Kpod or Lucifer Etomidate KPod are engineered to support strictly controlled, short-term research scenarios.
For further information on test standards and handling, refer to About Our Laboratory-Tested Etomidate Purity Standards.
Guidance on Usage and Caution
Cautious, ethical administration is central to etomidate research. Certain populations and conditions demand careful review or indicate avoidance altogether.
Considerations for sepsis and critically ill subjects:
Subjects experiencing sepsis or critical illness risk relative adrenal insufficiency with etomidate exposure. Studies in these models require thorough justification, alternate agent consideration, and robust safety protocols.
Adrenal insufficiency risks:
Any history or suspicion of baseline adrenal dysfunction should prompt exclusion due to heightened suppression risk.
Pregnancy and special population advisories:
Experimental use in pregnant or lactating subjects, minors, or individuals with unclear health status is prohibited by research ethics standards and local regulations. Defer to institutional and jurisdictional guidelines.
Researchers must align all acquisition and use of etomidate with ethical review standards, import/export constraints, and subject safety protocols. For information on logistics, privacy, and compliance with international regulations, reference Information on Discreet Worldwide Shipping.
Dosing and Administration Basics
All information here is strictly for qualified laboratory personnel operating in compliance with research governance. It is not a substitute for clinical protocol or patient care guidance.
Pharmaceutical-grade etomidate is distributed as highly pure powder or in advanced pod systems, each with calibrated dosing and preparation documentation. Rigorous protocols and monitoring are a prerequisite for use.
Standard intravenous dosing guidelines:
Most protocols specify 0.3 mg/kg administered intravenously in a single exposure to induce hypnosis.
Measured onset occurs within roughly 30–60 seconds; recovery follows in 5–15 minutes barring protocol-specific deviations.
Pod system dosing and administration must conform to device specifications and laboratory procedure manuals.
Pre-administration safety checklist:
Confirm adult status (21+), pregnancy exclusion, and no history of adrenal disorders.
Review and adhere to institutional approval processes.
Ensure fully functional monitoring for cardiovascular and airway status.
Prepare for emergency intervention in event of hypotension, adrenal crisis, or airway events.
Fully document and obtain consent for any at-risk models or protocols.
Monitoring recommendations during and after dosing:
Continuous cardiovascular and respiratory tracking throughout exposure and emergence.
Identify and document myoclonus, nausea, or unexpected delayed recovery promptly.
Monitor adrenal profiles in protocols that extend exposure or involve post-stress assessments.
Pharmaceutical-grade powders and pod-system options are available to support a wide range of research needs, from protocol-driven small studies to larger scale investigations. See Browse Pharmaceutical-grade Etomidate Products for up-to-date inventory, laboratory batch documentation, and device/system specifications matched to experimental needs, including Marbo Etomidate K-pod and Gucci Etomidate K-Pod configurations.
Best Practice Considerations in Research Use
Selecting etomidate as the hypnotic agent of choice in research studies involves balancing its unique benefits against the documented risks and considering logistics such as shipping, privacy, and local regulatory issues. Many laboratories prefer the privacy and reliability offered by cryptocurrency payments and Stealth packaging, minimizing risk of interference or exposure.
Research Scenario
Etomidate Advantages
Main Risks
Recommended Alternatives
Induction in unstable hemodynamics
Maintains blood pressure/cardiac output
Adrenal suppression
Agents with less impact on adrenal physiology
Rapid sequence intubation (RSI)
Rapid onset, preserves hemodynamics
Myoclonus, adrenal suppression
Consider alternative hypnotics if suitable
Short procedural sedation (labs)
Fast onset, brief effect Window
Injection pain, adrenal risk
Local anesthetics or benzodiazepines
Critically ill/septic subjects
Hemodynamic stability possible
High risk for adrenal crisis
Often best to avoid unless no alternatives
Repeated/prolonged dosing
N/A
Severe adrenal suppression
Not recommended; use alternatives
Best practice strategies:
Limit administration to single or minimal exposures.
Exclude vulnerable populations whenever possible.
Employ careful pre-administration screening and ongoing monitoring.
Mitigate myoclonus with pre-treatment or alternative protocol designs.
Request and retain comprehensive batch documentation to confirm laboratory analytic purity.
Logistics, privacy, and cross-border research requirements are addressed with secure packaging, tracked shipments, and delivery guarantees. To learn more, visit Information on Discreet Worldwide Shipping.
Frequently Asked Questions About Etomidate
What is etomidate used for?
Etomidate is utilized for the induction of general anesthesia and for short-term hypnosis in laboratory research, particularly when hemodynamic stability is required.
Why is etomidate preferred in some intubations?
It preserves blood pressure and heart rate during induction, which is critical where cardiovascular fluctuations would complicate research or patient safety.
Does etomidate lower blood pressure?
Etomidate generally maintains blood pressure at recommended doses, differing from many hypnotic or anesthetic competitors.
What is the main risk of etomidate?
The primary safety concern is transient suppression of adrenal steroid synthesis, which can be harmful in stress, infection, or prolonged protocols.
How long does adrenal suppression last?
Adrenal suppression from a typical dose may last six to twenty-four hours. The risk grows with repeated dosing or in vulnerable subjects.
Is etomidate safe in sepsis or shock?
Use in septic or shocked models is controversial, as adrenal crisis is possible. Expert consultation and alternative choices are advised.
What causes etomidate-induced myoclonus?
Transient disinhibition of central nervous system pathways leads to muscle jerking, which may require protocol modifications or additional agents to minimize.
Can etomidate be used for procedural sedation?
Etomidate can provide short procedural sedation under strict protocols, but is not appropriate for repeated or extended sedation due to cumulative endocrine effects.
What are common side effects after administration?
Myoclonus, pain or burning at the administration site, and transient nausea or vomiting are regularly observed, though typically mild.
How does etomidate differ from other induction agents?
Etomidate"s neutral effect on blood pressure and cardiac output distinguishes it from other anesthetics, but its potential for adrenal suppression requires more careful oversight.
To address additional queries or detail, see Frequently Asked Questions about Etomidate and Research Chemicals.
Compliance and Safety Notice:
All etomidate products - powder and pod-based - are intended strictly for research purposes in adult (21+) laboratories and qualified professional environments. Not for any form of human consumption, direct clinical treatment, or sale to minors. Researchers must review and comply with all institutional, legal, and regulatory requirements prior to purchase or handling. The information presented is informational and not clinical advice; no warranty of suitability for unauthorized uses is implied.
Discerning laboratories and scientific professionals can rely on our commitment to rigorous analytic standards, complete privacy, and global accessibility. Every order is handled with same-day dispatch, privacy-centric packaging, and delivery guarantees, supported by cryptocurrency payment processing for unmatched discretion.
For product information, specialized batch needs, or to discuss research logistics, Contact Us for Research-Grade Etomidate Inquiries.
https://etomidatekpods.com
https://etomidatekpods.com
https://etomidatekpods.com
Raktiniai žodžiai: The Science Behind Etomidate: Uses, Benefits, and Risks
Kontaktinis adresas:
Jurbarko raj.
Kontaktinis asmuo:
wayne johnson
Kontaktinis telefonas:
02921283652
Svetainė:
Skelbimas peržiūrėtas:
39
Skelbimo ID:
163544
Skelbimas įkeltas:
2026-09-02 17:35:02
Skelbimo nuoroda:
Skelbimai Didžiojoje Britanijoje
Rekomenduojami skelbimai
Išvažiuojamieji Banketai, Furšetai, Vestuvės, Gim...
20.00 €
20.00 €
Nebrangiai vedu buhalterinę apskaitą
1.00 €
1.00 €
Vertimų biuras BALTIC TRANSLATIONS
1.00 €
1.00 €
Užsakyti skelbimą
Kaina: Sutartinė
Kaina: Sutartinė
Užsakyti skelbimą
Kaina: Sutartinė
Kaina: Sutartinė
Užsakyti skelbimą
Kaina: Sutartinė
Kaina: Sutartinė
Įdėti skelbimą
Mano skelbimai